AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02616289 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Topical emollient (Sun Flower seed oil)
Description: 3 g of oil per kg of infant's weight at study entry of Sunflower Seed oil (SSO) will be applied three times per day at regularly spaced intervals (8-hour intervals) for 10 days. Oil will not be applied to the face (to avoid the possibility of any accidental aspiration or ingestion), ears or under the hairline. Care will be taken to not injure the skin during the massage treatment. The child's anal area will be washed prior to application to avoid the spread fecal flora from the anal region (to which the oil will be applied to last). Prior to bathing the child a minimum of 3-4 hours should have elapsed following the application of the SSO. The amount of oil required will be calculated based on the child's weight and the required amount weighed out each time.
Study NCT03882814 — intervention group
Intervention type: DRUG
Intervention: pethidine
Description: Pethidine 50 mg intramuscular (IM) injection was performed when cervical dilatation was at or greater than 4 cm and the cardiotocogram uterine contraction recordings of 200 Montevideo units was reached. Opioid analgesia (pethidine HCl - 50 mg I.M.) was given following amniotomy.
Study NCT03882814 — intervention group
Intervention type: DRUG
Intervention: Placebo - Concentrate
Description: Intramuscular saline was administered to the control group as placebo. Salin intramuscular (IM) injection was performed when cervical dilatation was at or greater than 4 cm and the cardiotocogram uterine contraction recordings of 200 Montevideo units was reached. salon was given following amniotomy.
Study NCT02915523 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: entinostat
Description: An orally available histone deacetylases inhibitor (HDACi).
Study NCT02915523 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: avelumab
Description: A fully human antibody of the immunoglobulin (Ig) G1 isotype that targets and blocks Programmed death-ligand 1 (PD-L1), the ligand for Programmed cell death protein 1 (PD-1) receptor.
Study NCT02915523 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: avelumab
Description: A fully human antibody of the immunoglobulin (Ig) G1 isotype that targets and blocks Programmed death-ligand 1 (PD-L1), the ligand for Programmed cell death protein 1 (PD-1) receptor.
Study NCT02915523 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A pill containing no active drug ingredient.
Study NCT03940859 — intervention group
Intervention type: DEVICE
Intervention: intracranial stent, flow diverter and coils
Description: Endovascular treatment was performed under general anesthesia. Patients were treated with internal trapping, stent-assisted coiling or flow diverter as appropriate. After the procedure, patients treated with conventional stent were given 75mg/d clopidogrel for 6 weeks and 100mg/d aspirin for 6months, while patients treated with flow diverter were given 75mg/d clopidogrel for 3 months and 100mg/d aspirin thereafter. All patients were recommended to undergo a 6-month angiographic follow-up.
Study NCT01685463 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: Active TMS:1 Hz, 100% motor threshold TMS for 15 minutes, total 900 pulses. Electrical stimulation instead.
Study NCT01685463 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham Transcranial Magnetic Stimulation
Description: The electrical current of the sham system is titrated to a level matching participants' ratings of active TMS. The sham-TMS scalp discomfort will be matched to that of active TMS.
Study NCT03884738 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Concentric Exercise
Description: Leg Curl Machine: 1st week - 1st day is 10 maximum repeat test. 2nd week - 2 days of training - 2 sets of 6 repeats. %60 percent of maximum load.~3rd week - 3 days of training - 3 sets of 6-8 repeats. %60-80 of maximum load. 4th-8th week - 3 days of training - 3 sets of 8-12 repeats. when 3 sets of 12 achieved, load was increased with 2.5kg.
Study NCT03884738 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nordic Eccentric exercise
Description: 1. st week - 1 day - 2 sets of 5 repeats.~2. nd week - 2 days - 2 sets of 6 repeats.~3. rd week - 3 days - 3 sets of 6-8 repeats.~4. th week - 3 days - 3 sets of 8-10 repeats. 5-8th weeks - 3 days - 3 sets of 12-8 repeats. When achieved 3 sets of 12 repeats with full range, speed was increased.
Study NCT03884738 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neuromuscular Electrical Stimulation
Description: 8 weeks, three times per week, 15 minutes of bilateral hamstring stimulation. 100 Hz. frequency, 600 microsecond duration rectangular current
Study NCT02713958 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Description: Telerehabilitation: Telerehabilitation treatment using a computerized system (MediTouch) for improving the elbow motion
Study NCT02713958 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation
Description: Traditional Occupational Therapy treatment: Active exercises for elbow motion
Study NCT00123006 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Dietary Approaches to Stop Hypertension (DASH)
Description: 4 week feeding intervention
Study NCT00123006 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control Diet
Description: 4 week feeding intervention
Study NCT03927001 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: NeVa Stent Retrievers
Description: mechanical neurothrombectomy
Study NCT03326076 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Donor-derived cell-free DNA (AlloSure®)
Description: Patients will receive donor-derived cell-free DNA testing for surveillance and for-cause. The planned surveillance will occur at months 1, 2, 3, 4, 6, 9, and 12 post-transplant and quarterly in year 2 and year 3.
Study NCT03326076 — intervention group
Intervention type: OTHER
Intervention: Standard care
Description: Current standard methods for monitoring of renal allograft recipients for rejection (e.g. donor-specific antibodies, serum creatinine, proteinuria, renal allograft biopsy)
Study NCT03326076 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Peripheral blood gene expression profiling (AlloMap Kidney)
Description: Patients will receive peripheral blood gene expression profiling testing for surveillance and for-cause. The planned surveillance will occur at months 1, 2, 3, 4, 6, 9, and 12 post-transplant and quarterly in year 2 and year 3.
Study NCT03326076 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Analytic platform (IBox)
Description: Patients will receive IBox testing for surveillance and for-cause. The planned surveillance will occur at months 1, 2, 3, 4, 6, 9, and 12 post-transplant and quarterly in year 2 and year 3.
Study NCT00535132 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Risperidone
Description: 4 or 6 mg MG once daily for 0-2 weeks
Study NCT00535132 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paliperidone ER
Description: 6, 9 or 12 MG once daily for 4-6 weeks
Study NCT03488875 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mMBRT
Description: Madison Mindfulness-Based Resilience Training (mMBRT) is an 8-week mindfulness-based intervention developed specifically for police officers, which is similar to and inspired by a program developed by researchers at Pacific (OR) University (Christopher, Goerling et al., 2016). mMBRT includes 8 weekly 2-hour classes involving guided meditation practice, gentle movement, and group-based discussion (the 7th class is a longer, 4-hour class). The total class time is about 18 hours over 8 weeks, and participants are asked to engage in home practice for up to 30 minutes/day, 6 days/week throughout the intervention.
Study NCT01674101 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Endurance
Description: Endurance exercise will consist of ambulating with assistive devices as needed, upper extremity (UE) ergometer, and/or playing the Wii.
Study NCT01674101 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strengthening
Description: Strengthening exercises will involve both UE's and LE's. For UE's, bicep curls, triceps curls, shoulder flexion, and/or press-ups from the therapy mat or wheelchair will be included. For the LE's, bridging, long arc quads, hamstring curls, calf raises in standing, single LE squats, and/or dorsiflexion (DF) in supine will be performed on the uninvolved extremity.
Study NCT01674101 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching
Description: Stretching will consist of ankle stretch into DF in supine or long sitting, hamstring stretch in supine with hip flexed to 90 degrees, and trunk extension in sitting.
Study NCT01674101 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home exercise program
Description: All participants will be given a tailored home exercise program (HEP) including endurance exercises, strengthening, and stretching exercises to be completed on days they do not have PT. If the participants return home, they will be asked to complete the HEP at least 3 days per week. The physical therapist will contact the participant weekly to modify the HEP if necessary and determine compliance.
Study NCT02956551 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DC vaccine
Description: subcutaneous administration
Study NCT02766738 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GrACE program
Description: to compare with the GrACE + gait programme in RAC, as well as the secondary objective of measuring the programme benefits on gait speed, sit to stand and handgrip strength against the intervention and control group
Study NCT02766738 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GrACE + gait
Description: to compare with the GrACE programme in RAC, as well as the secondary objective of measuring the programme benefits on gait speed, sit to stand and handgrip strength against the intervention and control group
Study NCT00729456 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Education
Description: Patients receive a single session, one-to-one workshop (carers may be included if appropriate) in their own home, lasting 60 - 120 minutes.
Study NCT02389127 — intervention group
Intervention type: DEVICE
Intervention: Continuous glucose monitor (Dexcom, San Diego, CA)
Description: (Group B) patients with known diabetes and cirrhosis with varying degrees of liver dysfunction will wear a continuous glucose monitor (Dexcom, San Diego, CA) for 2 continuous days during week days and week ends, every 4 weeks for 12 consecutive weeks.
Study NCT02246062 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: info
Description: the relative received leaflet containing information about the anesthetic procedure one day before the surgery at ward.
Study NCT02246062 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: smartphone
Description: the child received smartphone application immediately before entering the operating room
Study NCT02919436 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamsulosin
Description: Active drug
Study NCT02919436 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Lactose-filled capsules identical to active drug
Study NCT03130244 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Magnet Anastomosis System
Description: The MAS will be placed using an endoscope in the duodenum and and laparoscopically into ileum. A compression anastomosis will be created in each of the patients and the diversion of enteral flow from the duodenum to ileum treats Type 2 diabetes.
Study NCT03130244 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Best Medical Management
Description: The best medical management for the patients in this arm will be decided by the endocrinologist based on protocol parameters.
Study NCT04718974 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mHealth call for life system/ tool using IVR ( interactive voice response)
Description: The tool capitalises on a basic mobile phone's core utilities of voice and short messaging services. The system design, development, testing and evaluation was done by Janssen and the Grameen Foundation (http://motechsuite.org/index.php/implementations). In 2015, Janssen Global Public Health Research and Development, in close collaboration with the Infectious Diseases Institute Kampala (IDI), developed Call for Life Uganda (CFLU) tailored to the needs of PLHIV in Uganda
Study NCT04435509 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 1000+ Greek Mountain Tea
Description: Dietary Supplement: Greek Mountain Tea dietary intake of the content of 12 grams (4 grams 3 times per day ) 50 grams per month
Study NCT04435509 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Mediterranean Diet
Description: a Mediterranean dietary protocol
Study NCT03259074 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo to AIN457 150 mg dose administered with AIN457 via pre-filled syringes
Study NCT03259074 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: GP2017 (adalimumab biosimilar)
Description: 40 mg in pre-filled syringes was administered subcutaneously
Study NCT03259074 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AIN457 150 mg
Description: 150 mg in pre-filled syringes was administered subcutaneously
Study NCT02410135 — intervention group
Intervention type: DRUG
Intervention: Mirabegron
Description: 25 mg PO per day for four weeks. if tolerated then uptitrated to 50 mg PO per day for the remaining 8 weeks
Study NCT06126432 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Yugart
Description: Yugart 2 bottles per day for 1 month
Study NCT01890603 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Data collection
Description: Research involving materials (data, documents, records, or specimens) that have been collected, or will be collected, solely for non-research purposes (such as medical treatment or diagnosis).
Study NCT01890603 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Data Collection
Description: Research involving materials (data, documents, records, or specimens) that have been collected, or will be collected, solely for non-research purposes (such as medical treatment or diagnosis).
Study NCT04550598 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HD-tCES
Description: The high definition transcranial electrical stimulation was applied using a 1\*4 ring electrode configuration. The electrode will be applied at the left M1 or contralateral to pain side. The anodal electrode was placed on the C3/C4, and the remaining 4 cathodal electrodes were placed in a radius of approximately 7.5 cm from anode (Cz, F3, T7, and P3 on the left hemisphere or Cz, F4, T8, and P4 on the right hemisphere). HD-tCES will be applied for 20 minutes at an intensity of 1.0 mA direct current stimulation and a specific-added waveform each time, 5 times a week, lasting for 2 weeks.
Study NCT01755715 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Immediate IUD insertion
Description: Insertion of LNG-IUD (Mirena) (at the same day to 3 days) after expulsion of placenta.
Study NCT03294785 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chuna manual therapy
Description: Chuna is a Korean manual therapy that has absorbed and incorporated aspects of osteopathic manipulative medicine. Chuna manual therapy utilizes spinal manipulation techniques for joint mobilization including high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement, muscle energy, and fascial techniques.
Study NCT03294785 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Conventional medication
Description: Conventional drugs will be prescribed in an individually-tailored, pragmatic method with reference to most frequently used treatments in patients with a primary diagnosis of cervical sprain/strain group, cervical disc disorder with radiculopathy group, or cervicalgia according to Korean Health Insurance Review and Assessment (HIRA) 2014 statistics.
Study NCT03294785 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Physical therapy
Description: Physical therapy will be prescribed in an individually-tailored, pragmatic method with reference to most frequently used treatments in patients with a primary diagnosis of cervical sprain/strain group, cervical disc disorder with radiculopathy group, or cervicalgia according to Korean Health Insurance Review and Assessment (HIRA) 2014 statistics.
Study NCT00730938 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cefuroxime
Description: intracameral cefuroxime 0.1 ml
Study NCT00730938 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline placebo
Description: 0.1 ml of Ringers lactate
Study NCT03760900 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Autologous Umbilical Cord Blood Stem Cells Therapy
Description: Autologous Umbilical Cord Blood Stem Cells Therapy,the dose is 5×107cells/kg, within 24 hours after birth
Study NCT02723500 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Hyperpolarized Xenon MRI
Description: Hyperpolarized noble gas imaging using Xenon-129 has been used to explore structural and functional relationships in the lung in patients with lung disease and healthy controls. In contrast to proton-based MRI imaging, 129Xe gas is used as a contrast agent to directly visualize the airways, and thus ventilation. Whereas the normal density of gas is too low to produce an easily detectable signal, this is overcome by artificially increasing the amount of polarization per unit volume using optical pumping.
Study NCT04550598 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham HD-tCES
Description: The high definition transcranial electrical stimulation was applied using a 1\*4 ring electrode configuration. The electrode will be applied at the left M1 or contralateral to pain side. The anodal electrode was placed on the C3/C4, and the remaining 4 cathodal electrodes were placed in a radius of approximately 7.5 cm from anode (Cz, F3, T7, and P3 on the left hemisphere or Cz, F4, T8, and P4 on the right hemisphere). Sham HD-tCES will consist of a 5-second ramp up to 1.0 mA direct current stimulation and a specific-added waveform followed immediately by a 5-second ramp down, no current in the middle 19 minutes 40 seconds, and a ramp-up and ramp-down period during the last 10 seconds.
Study NCT03236662 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (-)-Epicatechin
Study NCT04163172 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical treatment of distal humeral fracture with elbow hemiarthroplasty
Description: Latitude anatomical elbow hemiarthroplasty (WRIGHT -Memphis, Tennessee)
Study NCT04163172 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical treatment of distal humeral fracture with double plating.
Description: Double plating (Synthes - Switzerland and West Chester, Pennsylvania, United States)
Study NCT01913496 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: ebalance
Description: using the ebalance application for 14 weeks
Study NCT01913496 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ebalance
Description: using the ebalance application for 14 weeks
Study NCT03799042 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: Subjects will wear a 3D glass and watch 3D pictures (or video) of landscapes or tourist sites in Hong Kong.
Study NCT03799042 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Inter-generation interaction
Description: Secondary school student will play games and chats with secondary school students. Games involve identifying famous landscapes or tourist sites in Hong Kong
Study NCT01910935 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity prescription to develop program in group.
Description: Overall the intervention involves a medical reference in primary care (PHC) to hypertensive patients (during routine consultation) to assist the sports facilities of the same Institute, to develop a group program of physical activity which will last 24 weeks. Led by the trained staff in physical activity to patients with chronic diseases.
Study NCT00856518 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: EMST
Description: Pressure threshold device (Expiratory Muscle Strength Trainer) targeted at increase muscle force generation of expiratory and submental muscles.
Study NCT02128230 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: myPRS
Description: Genome expression profiling used to identify high-risk and low-risk multiple myeloma
Study NCT02128230 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Induction 1 - MEL-10+CFZ-TD-PACE
Description: Melphalan (MEL) and Carfilzomib (CFZ) will be given into a central venous catheter. Thalidomide (T) is a capsule and Dexamethasone (D) is a pill; both will be taken by mouth. Cisplatin (P), Adriamycin (A), Cyclophosphamide (C) and Etoposide (E) are all given into the vein (IV) by a continuous infusion through a central catheter. After completion of the continuous chemotherapy, Granulocyte colony-stimulating factor (G-CSF), a shot just under the skin to help the bone marrow and blood counts recover more quickly after chemotherapy, will be given.~Regimen: CFZ 20 mg/m2 on days 1, 5, \& 6; MEL 10mg/m2 on day 3; T 200 mg/d, D 40 mg/d, P 10 mg/m2/d, A 10 mg/m2/d, C 400 mg/m2/d, and E 40 mg/m2/d on days 5-8; G-CSF 10 mcg/kg/day from day 11 through end of Peripheral Blood Stem Cell (PBSC) collection.~Optional Bridging with T 50 mg/d and D 20 mg on day 1-4 every 21 days until 1st transplant.